In conclusion, these data may indicate that HIPPO-pathway activation is physiologically conducted via NKX6-3 in BCPs and aberrantly via TCF3::PBX1 in BCP-ALL. This evidence concerns the gene NKX6-3 and acute lymphoblastic leukemia.